Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer
Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer
复制标题
导致结肠癌的疾病中结肠上皮细胞的第一期和第二期增殖性病变
作者:
M. Lipkin
Colonic epithelial cells in man begin to develop some of the characteristics of malignant cells while they still appear normal on conventional morphological examination. The cells pass through specific phases during which they express increasingly abnormal proliferative characteristics. As a Phase 1 proliferative lesion develops, colonic epithelial cells do not repress DNA synthesis during their maturation, and begin to develop an enhanced ability to proliferate. The over‐all kinetics of cell proliferation remain normal, without a net retention or accumulation of cells in the mucosa. As a Phase 2 proliferative lesion forms, the cells begin to develop properties that enable them to be retained in the mucosa in increasing numbers. The over‐all kinetics of cell proliferation become abnormal, and net retention and accumulation of cells begin to be observed. These changes are accompanied by differentiation‐specific molecular errors, resulting in the abnormal persistence of metabolic pathways leading to enhanced DNA synthesis. These proliferative cellular lesions arise in hereditary familial polyposis in man, in individuals in the general population who develop isolated colonic neoplasms, and in rodents after a chemical carcinogen is given, suggesting that they are major steps on a final common molecular pathway leading to malignant transformation. Their expression is accelerated in familial polyposis. The proliferative lesions and increasingly severe degrees of cellular atypia can be screened in familial polyposis, the utility of the screening procedure is being studied. The molecular lesions leading to persistent DNA synthesis, the interaction of suspected carcinogens leading to the appearance of the above changes in model systems, and the development of more effective chemotherapy and immunotherapy against the reactions leading to enhanced DNA synthesis are topics of importance at the present time.